[O-12] Oral Session 12

[O-12-1] Efficacy of nanomicelle-encapsulated anti-amyloid β oligomer fragment antibody in AD pathology

^○Nobuo Sanjo¹, Akiko Amano¹, Wataru Araki¹, Yasutaka Anraku^2,3, Makoto Nakakido^2,4, Etsuro Matsubara⁵, Kousei Hirata¹, Tetsuya Nagata¹, Kouhei Tsumoto^1,4,6, Kazunori Kataoka³, Takanori Yokota¹ (1.Tokyo Medical and Dental University, Department of Neurology and Neurological Science, Japan, 2.The University of Tokyo, Department of Bioengineering, School of Engineering, 3.Innovation Center of NanoMedicine, Kawasaki Institute of Industry Promotion, 4.The University of Tokyo, Department of Chemistry & Biotechnology, School of Engineering, 5.Oita University, Department of Neurology, 6.The University of Tokyo, The Institute of Medical Science)